搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
16 天
君实生物与微境生物合作开发!1类癌症新药获批临床
今日(9月26日),中国国家药监局药品审评中心(CDE)官网新公示,君实生物申报的WJ47156片获得临床试验默示许可,拟开发治疗晚期恶性肿瘤。根据君实生物此前公告介绍,WJ47156片(项目代号“JS125”)是其与微境生物医药合作开发的1类创新药,为一款靶向组蛋白去乙酰化酶(HDACs)抑制剂,属于表观遗传调控剂类药物。 表观遗传学指的是一种可逆的遗传机制,它可以在不改变DNA序列的情况下,通 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Indicted on 6 felony counts
How to help Milton victims
Drownings were avoidable?
Man attacked, killed by dogs
Nobel Peace Prize awarded
Carne asada drug bust
Coast Guard rescues man
Gators displaced by Milton
Requests military aircraft
Meningitis outbreak sentence
To close 444 stores
CA rejects SpaceX plan
Admonishes Black men
Russia cements ties with Iran
Loses bid to get on PA ballot
Drug for hemophilia approved
Gets 2 years for role in riot
FTX exec heads to prison
JPMorgan says soft landing
Assets hit $11.5 trillion
Fidelity data breach
To cut workforce by 10%
Gets Walk of Fame star
US producer prices flat
Calls for relief funding
US consumer sentiment slips
Files suit against Virginia
Adds 8 new destinations
Mr. Bungle ex-member guilty
反馈